Filing Details
- Accession Number:
- 0001093557-22-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-20 17:35:31
- Reporting Period:
- 2022-01-18
- Accepted Time:
- 2022-01-20 17:35:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286858 | R Kevin Sayer | 6340 Sequence Drive San Diego CA 92121 | Chairman, Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-01-18 | 3,000 | $438.81 | 78,705 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-01-18 | 38,586 | $0.00 | 117,291 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2022-01-18 | 19,674 | $435.06 | 97,617 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
- Represents performance stock units ("PSUs") granted to the reporting person on March 8, 2019 that vested on January 18, 2022, with the applicable performance achieved.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Billionaire Hedge Funds
